title: Management of colorectal T1 carcinoma treated by endoscopic resection.
abstract: As a result of recent advances in endoscopic therapeutic technology, the number of endoscopic resections carried out in the treatment of early colorectal carcinomas with little risk of lymph node metastasis has increased. There are no reports of lymph node metastasis in intramucosal (Tis) carcinomas, whereas lymph node metastasis occurs in 6.8-17.8% of submucosal (T1) carcinomas. Three clinical guidelines have been published in Japan and the management strategy for early colorectal tumors has been demonstrated. According to the 2014 Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines for the Treatment of Colorectal Cancer, additional surgery should be done in cases of endoscopically resected T1 carcinoma with a histologically diagnosed positive vertical margin. Additional surgery may also be considered when one of the following histological findings is detected: (i) SM invasion depth ≥1000 µm; (ii) histological type por., sig., or muc.; (iii) grade 2-3 tumor budding; and (iv) positive vascular permeation. A resected lesion that is histologically diagnosed as a T1 carcinoma without any of the above-mentioned findings can be followed up without additional surgery. As for the prognosis of endoscopically resected T1 carcinomas, the relapse ratio of approximately 3.4% (44/1312) is relatively low. However, relapse is associated with a poor prognosis, with 72 cancer-related deaths reported out of 134 relapsed cases (54%). A more detailed stratification of the lymph node metastasis risk after endoscopic resection for T1 carcinomas and the prognosis of relapsed cases will be elucidated through prospective studies. Thereafter, the appropriate indications and safe and secure endoscopic resection for T1 carcinomas will be established.
authors.affiliation: Digestive Disease Center, Asahikawa City Hospital, Japan.
authors.forename: Yusuke
authors.initials: Y
authors.lastname: Saitoh
authors.affiliation: Digestive Disease Center, Asahikawa City Hospital, Japan.
authors.forename: Yuhei
authors.initials: Y
authors.lastname: Inaba
authors.affiliation: Digestive Disease Center, Asahikawa City Hospital, Japan.
authors.forename: Takahiro
authors.initials: T
authors.lastname: Sasaki
authors.affiliation: Digestive Disease Center, Asahikawa City Hospital, Japan.
authors.forename: Ryuji
authors.initials: R
authors.lastname: Sugiyama
authors.affiliation: Digestive Disease Center, Asahikawa City Hospital, Japan.
authors.forename: Ryuji
authors.initials: R
authors.lastname: Sukegawa
authors.affiliation: Division of Gastroenterology and Hematology/Oncology, Department of Internal Medicine, Asahikawa Medical University, Asahikawa, Japan.
authors.forename: Mikihiro
authors.initials: M
authors.lastname: Fujiya
mesh_terms: D002277:Carcinoma / Q000473:pathology* / Q000601:surgery*; D003082:Colectomy; D003113:Colonoscopy; D015179:Colorectal Neoplasms / Q000473:pathology* / Q000601:surgery*; D006801:Humans; D007413:Intestinal Mucosa / Q000473:pathology; D009361:Neoplasm Invasiveness; D009367:Neoplasm Staging
keywords: endoscopic resection; lymph node metastasis; prognosis; recurrence; submucosal colorectal carcinoma